These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23855825)

  • 1. Identification of novel modulators for ionotropic glutamate receptor, iGluA2 by in-silico screening.
    Padmanabhan B
    Theor Biol Med Model; 2013 Jul; 10():46. PubMed ID: 23855825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the allosteric modulator binding site of GluR2 with thiazide derivatives.
    Ptak CP; Ahmed AH; Oswald RE
    Biochemistry; 2009 Sep; 48(36):8594-602. PubMed ID: 19673491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamics and structural analysis of positive allosteric modulation of the ionotropic glutamate receptor GluA2.
    Krintel C; Frydenvang K; Olsen L; Kristensen MT; de Barrios O; Naur P; Francotte P; Pirotte B; Gajhede M; Kastrup JS
    Biochem J; 2012 Jan; 441(1):173-8. PubMed ID: 21895609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,4-Benzothiadiazine-1,1-dioxide derivatives as ionotropic glutamate receptor ligands: synthesis and structure-activity relationships.
    Varano F; Catarzi D; Colotta V; Squarcialupi L; Matucci R
    Arch Pharm (Weinheim); 2014 Nov; 347(11):777-85. PubMed ID: 25204434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.
    Hald H; Ahring PK; Timmermann DB; Liljefors T; Gajhede M; Kastrup JS
    J Mol Biol; 2009 Sep; 391(5):906-17. PubMed ID: 19591837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators.
    Pøhlsgaard J; Frydenvang K; Madsen U; Kastrup JS
    Neuropharmacology; 2011 Jan; 60(1):135-50. PubMed ID: 20713069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics and allostery of the ionotropic glutamate receptors and the ligand binding domain.
    Tobi D
    Proteins; 2016 Feb; 84(2):267-77. PubMed ID: 26677170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
    Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H
    Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of anti-seizure medications on ionotropic glutamate receptors: special focus on AMPA receptor subunits.
    Fukushima K; Hatanaka K; Sagane K; Ido K
    Epilepsy Res; 2020 Nov; 167():106452. PubMed ID: 32911258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionotropic Glutamate Receptor GluA2 in Complex with Bicyclic Pyrimidinedione-Based Compounds: When Small Compound Modifications Have Distinct Effects on Binding Interactions.
    Frydenvang K; Pickering DS; Kshirsagar GU; Chemi G; Gemma S; Sprogøe D; Kærn AM; Brogi S; Campiani G; Butini S; Kastrup JS
    ACS Chem Neurosci; 2020 Jun; 11(12):1791-1800. PubMed ID: 32437601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular structure of ionotropic glutamate receptors.
    Kaczor AA; Matosiuk D
    Curr Med Chem; 2010; 17(24):2608-35. PubMed ID: 20491632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Potential Dual Negative Allosteric Modulators of Group I mGluR Family: A Shape Based Screening, ADME Prediction, Induced Fit Docking and Molecular Dynamics Approach Against Neurodegenerative Diseases.
    Prabhu SV; Singh SK
    Curr Top Med Chem; 2019; 19(29):2687-2707. PubMed ID: 31702505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
    Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
    ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters.
    Assaf Z; Larsen AP; Venskutonytė R; Han L; Abrahamsen B; Nielsen B; Gajhede M; Kastrup JS; Jensen AA; Pickering DS; Frydenvang K; Gefflaut T; Bunch L
    J Med Chem; 2013 Feb; 56(4):1614-28. PubMed ID: 23414088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of allosteric modulators of GPCRs for treatment of CNS disorders.
    Nickols HH; Conn PJ
    Neurobiol Dis; 2014 Jan; 61():55-71. PubMed ID: 24076101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the Quinoxalinedione Scaffold in the Construction of New Ligands for the Ionotropic Glutamate Receptors.
    Demmer CS; Rombach D; Liu N; Nielsen B; Pickering DS; Bunch L
    ACS Chem Neurosci; 2017 Nov; 8(11):2477-2495. PubMed ID: 28872835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors.
    Stenum-Berg C; Musgaard M; Chavez-Abiega S; Thisted CL; Barrella L; Biggin PC; Kristensen AS
    Mol Pharmacol; 2019 Dec; 96(6):835-850. PubMed ID: 31582576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel dualistic profile of an allosteric AMPA receptor modulator identified through studies on recombinant receptors, mouse hippocampal synapses and crystal structures.
    Christiansen GB; Harbak B; Hede SE; Gouliaev AH; Olsen L; Frydenvang K; Egebjerg J; Kastrup JS; Holm MM
    Neuroscience; 2015 Dec; 310():709-22. PubMed ID: 26450748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Pharmacology of Mono-, Di-, and Trialkyl-Substituted 7-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides Combined with X-ray Structure Analysis to Understand the Unexpected Structure-Activity Relationship at AMPA Receptors.
    Larsen AP; Francotte P; Frydenvang K; Tapken D; Goffin E; Fraikin P; Caignard DH; Lestage P; Danober L; Pirotte B; Kastrup JS
    ACS Chem Neurosci; 2016 Mar; 7(3):378-90. PubMed ID: 26771108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a New Positive Allosteric Modulator of AMPA Receptors - PAM-43: Specific Binding of the Ligand and its Ability to Potentiate AMPAR Currents.
    Vyunova TV; Andreeva LA; Shevchenko KV; Grigoriev VV; Palyulin VA; Lavrov MI; Bondarenko EV; Kalashnikova EE; Myasoedov NF
    Curr Mol Pharmacol; 2020; 13(3):216-223. PubMed ID: 32124706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.